Global LNP-mRNA Therapy Supply, Demand and Key Producers, 2026-2032
The global LNP-mRNA Therapy market size is expected to reach $ 823 million by 2032, rising at a market growth of 5.5% CAGR during the forecast period (2026-2032).
LNP-mRNA Therapy represents a cutting-edge biomedical technology that leverages the unique strengths of Lipid Nanoparticles (LNPs) and Messenger RNA (mRNA) to offer novel treatment avenues for various diseases. Serving as carriers, LNPs effectively shield mRNA from enzymatic degradation in the body and deliver it precisely to target cells. mRNA carries the genetic information necessary for synthesizing specific proteins; once inside cells, it directs the cells to produce these proteins, thereby triggering immune responses or repairing damaged tissues. This therapy demonstrates significant potential in treating cancers, genetic disorders, and infectious diseases. Its highly personalized and rapid-response characteristics have made LNP-mRNA Therapy a research focus in the biomedical field. By precisely regulating gene expression, LNP-mRNA Therapy provides patients with unprecedented treatment options, ushering in a new era of precision medicine.
The LNP-mRNA Therapy market is in a phase of rapid development. Following the successful application of COVID-19 vaccines, global R&D focus has expanded to areas such as cancer immunotherapy, rare genetic diseases, cardiovascular diseases, and regenerative medicine. With the optimization of intelligent delivery systems and the maturation of production processes, the market size is expected to maintain high growth over the next decade, driven by the needs of infectious disease control, large-scale data center-based vaccine production capabilities, investment in new energy medical technologies, and the trend towards precision medicine. Despite challenges such as cost, stability, and regulation, with policy support and capital investment in North America, Europe, and the Asia-Pacific region, LNP-mRNA technology is poised to become a core platform for next-generation biomedicine, driving the upgrading of the global pharmaceutical industry structure.
This report studies the global LNP-mRNA Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for LNP-mRNA Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of LNP-mRNA Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global LNP-mRNA Therapy total market, 2021-2032, (USD Million)
Global LNP-mRNA Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: LNP-mRNA Therapy total market, key domestic companies, and share, (USD Million)
Global LNP-mRNA Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global LNP-mRNA Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global LNP-mRNA Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global LNP-mRNA Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Genevant Sciences, Moderna, BioNTech, Pfizer, NanoVation Therapeutics, CureVac, Sanofi, Promab, Grand Pharm, Arcturus Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world LNP-mRNA Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global LNP-mRNA Therapy Market, By Region:
1. How big is the global LNP-mRNA Therapy market?
2. What is the demand of the global LNP-mRNA Therapy market?
3. What is the year over year growth of the global LNP-mRNA Therapy market?
4. What is the total value of the global LNP-mRNA Therapy market?
5. Who are the Major Players in the global LNP-mRNA Therapy market?
6. What are the growth factors driving the market demand?
LNP-mRNA Therapy represents a cutting-edge biomedical technology that leverages the unique strengths of Lipid Nanoparticles (LNPs) and Messenger RNA (mRNA) to offer novel treatment avenues for various diseases. Serving as carriers, LNPs effectively shield mRNA from enzymatic degradation in the body and deliver it precisely to target cells. mRNA carries the genetic information necessary for synthesizing specific proteins; once inside cells, it directs the cells to produce these proteins, thereby triggering immune responses or repairing damaged tissues. This therapy demonstrates significant potential in treating cancers, genetic disorders, and infectious diseases. Its highly personalized and rapid-response characteristics have made LNP-mRNA Therapy a research focus in the biomedical field. By precisely regulating gene expression, LNP-mRNA Therapy provides patients with unprecedented treatment options, ushering in a new era of precision medicine.
The LNP-mRNA Therapy market is in a phase of rapid development. Following the successful application of COVID-19 vaccines, global R&D focus has expanded to areas such as cancer immunotherapy, rare genetic diseases, cardiovascular diseases, and regenerative medicine. With the optimization of intelligent delivery systems and the maturation of production processes, the market size is expected to maintain high growth over the next decade, driven by the needs of infectious disease control, large-scale data center-based vaccine production capabilities, investment in new energy medical technologies, and the trend towards precision medicine. Despite challenges such as cost, stability, and regulation, with policy support and capital investment in North America, Europe, and the Asia-Pacific region, LNP-mRNA technology is poised to become a core platform for next-generation biomedicine, driving the upgrading of the global pharmaceutical industry structure.
This report studies the global LNP-mRNA Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for LNP-mRNA Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of LNP-mRNA Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global LNP-mRNA Therapy total market, 2021-2032, (USD Million)
Global LNP-mRNA Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: LNP-mRNA Therapy total market, key domestic companies, and share, (USD Million)
Global LNP-mRNA Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global LNP-mRNA Therapy total market by Type, CAGR, 2021-2032, (USD Million)
Global LNP-mRNA Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global LNP-mRNA Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Genevant Sciences, Moderna, BioNTech, Pfizer, NanoVation Therapeutics, CureVac, Sanofi, Promab, Grand Pharm, Arcturus Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world LNP-mRNA Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global LNP-mRNA Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Passive Targeting
- Active Targeting
- Vaccines
- Cancer Immunotherapy
- Genetic Disease Therapy
- Others
- Protein Replacement Therapy
- Immune Activation Therapy
- Gene Regulation Therapy
- Hospital
- Clinic
- Others
- Genevant Sciences
- Moderna
- BioNTech
- Pfizer
- NanoVation Therapeutics
- CureVac
- Sanofi
- Promab
- Grand Pharm
- Arcturus Therapeutics
- Synplogen
- CSPC
- Beijing JenKem Technology
- Starna Therapeutics
1. How big is the global LNP-mRNA Therapy market?
2. What is the demand of the global LNP-mRNA Therapy market?
3. What is the year over year growth of the global LNP-mRNA Therapy market?
4. What is the total value of the global LNP-mRNA Therapy market?
5. Who are the Major Players in the global LNP-mRNA Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 LNP-mRNA Therapy Introduction
1.2 World LNP-mRNA Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World LNP-mRNA Therapy Total Market by Region (by Headquarter Location)
1.3.1 World LNP-mRNA Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.3 China Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.4 Europe Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.5 Japan Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.8 India Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 LNP-mRNA Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World LNP-mRNA Therapy Consumption Value (2021-2032)
2.2 World LNP-mRNA Therapy Consumption Value by Region
2.2.1 World LNP-mRNA Therapy Consumption Value by Region (2021-2026)
2.2.2 World LNP-mRNA Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States LNP-mRNA Therapy Consumption Value (2021-2032)
2.4 China LNP-mRNA Therapy Consumption Value (2021-2032)
2.5 Europe LNP-mRNA Therapy Consumption Value (2021-2032)
2.6 Japan LNP-mRNA Therapy Consumption Value (2021-2032)
2.7 South Korea LNP-mRNA Therapy Consumption Value (2021-2032)
2.8 ASEAN LNP-mRNA Therapy Consumption Value (2021-2032)
2.9 India LNP-mRNA Therapy Consumption Value (2021-2032)
3 WORLD LNP-MRNA THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World LNP-mRNA Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global LNP-mRNA Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for LNP-mRNA Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for LNP-mRNA Therapy in 2025
3.3 LNP-mRNA Therapy Company Evaluation Quadrant
3.4 LNP-mRNA Therapy Market: Overall Company Footprint Analysis
3.4.1 LNP-mRNA Therapy Market: Region Footprint
3.4.2 LNP-mRNA Therapy Market: Company Product Type Footprint
3.4.3 LNP-mRNA Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: LNP-mRNA Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: LNP-mRNA Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: LNP-mRNA Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: LNP-mRNA Therapy Consumption Value Comparison
4.2.1 United States VS China: LNP-mRNA Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: LNP-mRNA Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based LNP-mRNA Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based LNP-mRNA Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies LNP-mRNA Therapy Revenue, (2021-2026)
4.4 China Based Companies LNP-mRNA Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based LNP-mRNA Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies LNP-mRNA Therapy Revenue, (2021-2026)
4.5 Rest of World Based LNP-mRNA Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based LNP-mRNA Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies LNP-mRNA Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World LNP-mRNA Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Passive Targeting
5.2.2 Active Targeting
5.3 Market Segment by Type
5.3.1 World LNP-mRNA Therapy Market Size by Type (2021-2026)
5.3.2 World LNP-mRNA Therapy Market Size by Type (2027-2032)
5.3.3 World LNP-mRNA Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TREATMENT DIRECTION
6.1 World LNP-mRNA Therapy Market Size Overview by Treatment Direction: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Treatment Direction
6.2.1 Vaccines
6.2.2 Cancer Immunotherapy
6.2.3 Genetic Disease Therapy
6.2.4 Others
6.3 Market Segment by Treatment Direction
6.3.1 World LNP-mRNA Therapy Market Size by Treatment Direction (2021-2026)
6.3.2 World LNP-mRNA Therapy Market Size by Treatment Direction (2027-2032)
6.3.3 World LNP-mRNA Therapy Market Size Market Share by Treatment Direction (2027-2032)
7 MARKET ANALYSIS BY MECHANISMS OF ACTION
7.1 World LNP-mRNA Therapy Market Size Overview by Mechanisms of Action: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Mechanisms of Action
7.2.1 Protein Replacement Therapy
7.2.2 Immune Activation Therapy
7.2.3 Gene Regulation Therapy
7.3 Market Segment by Mechanisms of Action
7.3.1 World LNP-mRNA Therapy Market Size by Mechanisms of Action (2021-2026)
7.3.2 World LNP-mRNA Therapy Market Size by Mechanisms of Action (2027-2032)
7.3.3 World LNP-mRNA Therapy Market Size Market Share by Mechanisms of Action (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World LNP-mRNA Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World LNP-mRNA Therapy Market Size by Application (2021-2026)
8.3.2 World LNP-mRNA Therapy Market Size by Application (2027-2032)
8.3.3 World LNP-mRNA Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Genevant Sciences
9.1.1 Genevant Sciences Details
9.1.2 Genevant Sciences Major Business
9.1.3 Genevant Sciences LNP-mRNA Therapy Product and Services
9.1.4 Genevant Sciences LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Genevant Sciences Recent Developments/Updates
9.1.6 Genevant Sciences Competitive Strengths & Weaknesses
9.2 Moderna
9.2.1 Moderna Details
9.2.2 Moderna Major Business
9.2.3 Moderna LNP-mRNA Therapy Product and Services
9.2.4 Moderna LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Moderna Recent Developments/Updates
9.2.6 Moderna Competitive Strengths & Weaknesses
9.3 BioNTech
9.3.1 BioNTech Details
9.3.2 BioNTech Major Business
9.3.3 BioNTech LNP-mRNA Therapy Product and Services
9.3.4 BioNTech LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 BioNTech Recent Developments/Updates
9.3.6 BioNTech Competitive Strengths & Weaknesses
9.4 Pfizer
9.4.1 Pfizer Details
9.4.2 Pfizer Major Business
9.4.3 Pfizer LNP-mRNA Therapy Product and Services
9.4.4 Pfizer LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Pfizer Recent Developments/Updates
9.4.6 Pfizer Competitive Strengths & Weaknesses
9.5 NanoVation Therapeutics
9.5.1 NanoVation Therapeutics Details
9.5.2 NanoVation Therapeutics Major Business
9.5.3 NanoVation Therapeutics LNP-mRNA Therapy Product and Services
9.5.4 NanoVation Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 NanoVation Therapeutics Recent Developments/Updates
9.5.6 NanoVation Therapeutics Competitive Strengths & Weaknesses
9.6 CureVac
9.6.1 CureVac Details
9.6.2 CureVac Major Business
9.6.3 CureVac LNP-mRNA Therapy Product and Services
9.6.4 CureVac LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 CureVac Recent Developments/Updates
9.6.6 CureVac Competitive Strengths & Weaknesses
9.7 Sanofi
9.7.1 Sanofi Details
9.7.2 Sanofi Major Business
9.7.3 Sanofi LNP-mRNA Therapy Product and Services
9.7.4 Sanofi LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Sanofi Recent Developments/Updates
9.7.6 Sanofi Competitive Strengths & Weaknesses
9.8 Promab
9.8.1 Promab Details
9.8.2 Promab Major Business
9.8.3 Promab LNP-mRNA Therapy Product and Services
9.8.4 Promab LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Promab Recent Developments/Updates
9.8.6 Promab Competitive Strengths & Weaknesses
9.9 Grand Pharm
9.9.1 Grand Pharm Details
9.9.2 Grand Pharm Major Business
9.9.3 Grand Pharm LNP-mRNA Therapy Product and Services
9.9.4 Grand Pharm LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Grand Pharm Recent Developments/Updates
9.9.6 Grand Pharm Competitive Strengths & Weaknesses
9.10 Arcturus Therapeutics
9.10.1 Arcturus Therapeutics Details
9.10.2 Arcturus Therapeutics Major Business
9.10.3 Arcturus Therapeutics LNP-mRNA Therapy Product and Services
9.10.4 Arcturus Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Arcturus Therapeutics Recent Developments/Updates
9.10.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
9.11 Synplogen
9.11.1 Synplogen Details
9.11.2 Synplogen Major Business
9.11.3 Synplogen LNP-mRNA Therapy Product and Services
9.11.4 Synplogen LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Synplogen Recent Developments/Updates
9.11.6 Synplogen Competitive Strengths & Weaknesses
9.12 CSPC
9.12.1 CSPC Details
9.12.2 CSPC Major Business
9.12.3 CSPC LNP-mRNA Therapy Product and Services
9.12.4 CSPC LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 CSPC Recent Developments/Updates
9.12.6 CSPC Competitive Strengths & Weaknesses
9.13 Beijing JenKem Technology
9.13.1 Beijing JenKem Technology Details
9.13.2 Beijing JenKem Technology Major Business
9.13.3 Beijing JenKem Technology LNP-mRNA Therapy Product and Services
9.13.4 Beijing JenKem Technology LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Beijing JenKem Technology Recent Developments/Updates
9.13.6 Beijing JenKem Technology Competitive Strengths & Weaknesses
9.14 Starna Therapeutics
9.14.1 Starna Therapeutics Details
9.14.2 Starna Therapeutics Major Business
9.14.3 Starna Therapeutics LNP-mRNA Therapy Product and Services
9.14.4 Starna Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Starna Therapeutics Recent Developments/Updates
9.14.6 Starna Therapeutics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 LNP-mRNA Therapy Industry Chain
10.2 LNP-mRNA Therapy Upstream Analysis
10.3 LNP-mRNA Therapy Midstream Analysis
10.4 LNP-mRNA Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 LNP-mRNA Therapy Introduction
1.2 World LNP-mRNA Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World LNP-mRNA Therapy Total Market by Region (by Headquarter Location)
1.3.1 World LNP-mRNA Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.3 China Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.4 Europe Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.5 Japan Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.3.8 India Based Company LNP-mRNA Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 LNP-mRNA Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World LNP-mRNA Therapy Consumption Value (2021-2032)
2.2 World LNP-mRNA Therapy Consumption Value by Region
2.2.1 World LNP-mRNA Therapy Consumption Value by Region (2021-2026)
2.2.2 World LNP-mRNA Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States LNP-mRNA Therapy Consumption Value (2021-2032)
2.4 China LNP-mRNA Therapy Consumption Value (2021-2032)
2.5 Europe LNP-mRNA Therapy Consumption Value (2021-2032)
2.6 Japan LNP-mRNA Therapy Consumption Value (2021-2032)
2.7 South Korea LNP-mRNA Therapy Consumption Value (2021-2032)
2.8 ASEAN LNP-mRNA Therapy Consumption Value (2021-2032)
2.9 India LNP-mRNA Therapy Consumption Value (2021-2032)
3 WORLD LNP-MRNA THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World LNP-mRNA Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global LNP-mRNA Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for LNP-mRNA Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for LNP-mRNA Therapy in 2025
3.3 LNP-mRNA Therapy Company Evaluation Quadrant
3.4 LNP-mRNA Therapy Market: Overall Company Footprint Analysis
3.4.1 LNP-mRNA Therapy Market: Region Footprint
3.4.2 LNP-mRNA Therapy Market: Company Product Type Footprint
3.4.3 LNP-mRNA Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: LNP-mRNA Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: LNP-mRNA Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: LNP-mRNA Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: LNP-mRNA Therapy Consumption Value Comparison
4.2.1 United States VS China: LNP-mRNA Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: LNP-mRNA Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based LNP-mRNA Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based LNP-mRNA Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies LNP-mRNA Therapy Revenue, (2021-2026)
4.4 China Based Companies LNP-mRNA Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based LNP-mRNA Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies LNP-mRNA Therapy Revenue, (2021-2026)
4.5 Rest of World Based LNP-mRNA Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based LNP-mRNA Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies LNP-mRNA Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World LNP-mRNA Therapy Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Passive Targeting
5.2.2 Active Targeting
5.3 Market Segment by Type
5.3.1 World LNP-mRNA Therapy Market Size by Type (2021-2026)
5.3.2 World LNP-mRNA Therapy Market Size by Type (2027-2032)
5.3.3 World LNP-mRNA Therapy Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TREATMENT DIRECTION
6.1 World LNP-mRNA Therapy Market Size Overview by Treatment Direction: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Treatment Direction
6.2.1 Vaccines
6.2.2 Cancer Immunotherapy
6.2.3 Genetic Disease Therapy
6.2.4 Others
6.3 Market Segment by Treatment Direction
6.3.1 World LNP-mRNA Therapy Market Size by Treatment Direction (2021-2026)
6.3.2 World LNP-mRNA Therapy Market Size by Treatment Direction (2027-2032)
6.3.3 World LNP-mRNA Therapy Market Size Market Share by Treatment Direction (2027-2032)
7 MARKET ANALYSIS BY MECHANISMS OF ACTION
7.1 World LNP-mRNA Therapy Market Size Overview by Mechanisms of Action: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Mechanisms of Action
7.2.1 Protein Replacement Therapy
7.2.2 Immune Activation Therapy
7.2.3 Gene Regulation Therapy
7.3 Market Segment by Mechanisms of Action
7.3.1 World LNP-mRNA Therapy Market Size by Mechanisms of Action (2021-2026)
7.3.2 World LNP-mRNA Therapy Market Size by Mechanisms of Action (2027-2032)
7.3.3 World LNP-mRNA Therapy Market Size Market Share by Mechanisms of Action (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World LNP-mRNA Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World LNP-mRNA Therapy Market Size by Application (2021-2026)
8.3.2 World LNP-mRNA Therapy Market Size by Application (2027-2032)
8.3.3 World LNP-mRNA Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Genevant Sciences
9.1.1 Genevant Sciences Details
9.1.2 Genevant Sciences Major Business
9.1.3 Genevant Sciences LNP-mRNA Therapy Product and Services
9.1.4 Genevant Sciences LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Genevant Sciences Recent Developments/Updates
9.1.6 Genevant Sciences Competitive Strengths & Weaknesses
9.2 Moderna
9.2.1 Moderna Details
9.2.2 Moderna Major Business
9.2.3 Moderna LNP-mRNA Therapy Product and Services
9.2.4 Moderna LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Moderna Recent Developments/Updates
9.2.6 Moderna Competitive Strengths & Weaknesses
9.3 BioNTech
9.3.1 BioNTech Details
9.3.2 BioNTech Major Business
9.3.3 BioNTech LNP-mRNA Therapy Product and Services
9.3.4 BioNTech LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 BioNTech Recent Developments/Updates
9.3.6 BioNTech Competitive Strengths & Weaknesses
9.4 Pfizer
9.4.1 Pfizer Details
9.4.2 Pfizer Major Business
9.4.3 Pfizer LNP-mRNA Therapy Product and Services
9.4.4 Pfizer LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Pfizer Recent Developments/Updates
9.4.6 Pfizer Competitive Strengths & Weaknesses
9.5 NanoVation Therapeutics
9.5.1 NanoVation Therapeutics Details
9.5.2 NanoVation Therapeutics Major Business
9.5.3 NanoVation Therapeutics LNP-mRNA Therapy Product and Services
9.5.4 NanoVation Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 NanoVation Therapeutics Recent Developments/Updates
9.5.6 NanoVation Therapeutics Competitive Strengths & Weaknesses
9.6 CureVac
9.6.1 CureVac Details
9.6.2 CureVac Major Business
9.6.3 CureVac LNP-mRNA Therapy Product and Services
9.6.4 CureVac LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 CureVac Recent Developments/Updates
9.6.6 CureVac Competitive Strengths & Weaknesses
9.7 Sanofi
9.7.1 Sanofi Details
9.7.2 Sanofi Major Business
9.7.3 Sanofi LNP-mRNA Therapy Product and Services
9.7.4 Sanofi LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Sanofi Recent Developments/Updates
9.7.6 Sanofi Competitive Strengths & Weaknesses
9.8 Promab
9.8.1 Promab Details
9.8.2 Promab Major Business
9.8.3 Promab LNP-mRNA Therapy Product and Services
9.8.4 Promab LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Promab Recent Developments/Updates
9.8.6 Promab Competitive Strengths & Weaknesses
9.9 Grand Pharm
9.9.1 Grand Pharm Details
9.9.2 Grand Pharm Major Business
9.9.3 Grand Pharm LNP-mRNA Therapy Product and Services
9.9.4 Grand Pharm LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Grand Pharm Recent Developments/Updates
9.9.6 Grand Pharm Competitive Strengths & Weaknesses
9.10 Arcturus Therapeutics
9.10.1 Arcturus Therapeutics Details
9.10.2 Arcturus Therapeutics Major Business
9.10.3 Arcturus Therapeutics LNP-mRNA Therapy Product and Services
9.10.4 Arcturus Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Arcturus Therapeutics Recent Developments/Updates
9.10.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
9.11 Synplogen
9.11.1 Synplogen Details
9.11.2 Synplogen Major Business
9.11.3 Synplogen LNP-mRNA Therapy Product and Services
9.11.4 Synplogen LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Synplogen Recent Developments/Updates
9.11.6 Synplogen Competitive Strengths & Weaknesses
9.12 CSPC
9.12.1 CSPC Details
9.12.2 CSPC Major Business
9.12.3 CSPC LNP-mRNA Therapy Product and Services
9.12.4 CSPC LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 CSPC Recent Developments/Updates
9.12.6 CSPC Competitive Strengths & Weaknesses
9.13 Beijing JenKem Technology
9.13.1 Beijing JenKem Technology Details
9.13.2 Beijing JenKem Technology Major Business
9.13.3 Beijing JenKem Technology LNP-mRNA Therapy Product and Services
9.13.4 Beijing JenKem Technology LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Beijing JenKem Technology Recent Developments/Updates
9.13.6 Beijing JenKem Technology Competitive Strengths & Weaknesses
9.14 Starna Therapeutics
9.14.1 Starna Therapeutics Details
9.14.2 Starna Therapeutics Major Business
9.14.3 Starna Therapeutics LNP-mRNA Therapy Product and Services
9.14.4 Starna Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Starna Therapeutics Recent Developments/Updates
9.14.6 Starna Therapeutics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 LNP-mRNA Therapy Industry Chain
10.2 LNP-mRNA Therapy Upstream Analysis
10.3 LNP-mRNA Therapy Midstream Analysis
10.4 LNP-mRNA Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World LNP-mRNA Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World LNP-mRNA Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World LNP-mRNA Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World LNP-mRNA Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World LNP-mRNA Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World LNP-mRNA Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World LNP-mRNA Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World LNP-mRNA Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World LNP-mRNA Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key LNP-mRNA Therapy Players in 2025
Table 12. World LNP-mRNA Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global LNP-mRNA Therapy Company Evaluation Quadrant
Table 14. Head Office of Key LNP-mRNA Therapy Players
Table 15. LNP-mRNA Therapy Market: Company Product Type Footprint
Table 16. LNP-mRNA Therapy Market: Company Product Application Footprint
Table 17. LNP-mRNA Therapy Mergers & Acquisitions Activity
Table 18. United States VS China LNP-mRNA Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China LNP-mRNA Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based LNP-mRNA Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies LNP-mRNA Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies LNP-mRNA Therapy Revenue Market Share (2021-2026)
Table 23. China Based LNP-mRNA Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies LNP-mRNA Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies LNP-mRNA Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based LNP-mRNA Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies LNP-mRNA Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies LNP-mRNA Therapy Revenue Market Share (2021-2026)
Table 29. World LNP-mRNA Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World LNP-mRNA Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World LNP-mRNA Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World LNP-mRNA Therapy Market Size by Treatment Direction, (USD Million), 2021 & 2025 & 2032
Table 33. World LNP-mRNA Therapy Market Size Value by Treatment Direction (2021-2026) & (USD Million)
Table 34. World LNP-mRNA Therapy Market Size by Treatment Direction (2027-2032) & (USD Million)
Table 35. World LNP-mRNA Therapy Market Size by Mechanisms of Action, (USD Million), 2021 & 2025 & 2032
Table 36. World LNP-mRNA Therapy Market Size Value by Mechanisms of Action (2021-2026) & (USD Million)
Table 37. World LNP-mRNA Therapy Market Size by Mechanisms of Action (2027-2032) & (USD Million)
Table 38. World LNP-mRNA Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World LNP-mRNA Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World LNP-mRNA Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Genevant Sciences Basic Information, Manufacturing Base and Competitors
Table 42. Genevant Sciences Major Business
Table 43. Genevant Sciences LNP-mRNA Therapy Product and Services
Table 44. Genevant Sciences LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Genevant Sciences Recent Developments/Updates
Table 46. Genevant Sciences Competitive Strengths & Weaknesses
Table 47. Moderna Basic Information, Manufacturing Base and Competitors
Table 48. Moderna Major Business
Table 49. Moderna LNP-mRNA Therapy Product and Services
Table 50. Moderna LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Moderna Recent Developments/Updates
Table 52. Moderna Competitive Strengths & Weaknesses
Table 53. BioNTech Basic Information, Manufacturing Base and Competitors
Table 54. BioNTech Major Business
Table 55. BioNTech LNP-mRNA Therapy Product and Services
Table 56. BioNTech LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. BioNTech Recent Developments/Updates
Table 58. BioNTech Competitive Strengths & Weaknesses
Table 59. Pfizer Basic Information, Manufacturing Base and Competitors
Table 60. Pfizer Major Business
Table 61. Pfizer LNP-mRNA Therapy Product and Services
Table 62. Pfizer LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Pfizer Recent Developments/Updates
Table 64. Pfizer Competitive Strengths & Weaknesses
Table 65. NanoVation Therapeutics Basic Information, Manufacturing Base and Competitors
Table 66. NanoVation Therapeutics Major Business
Table 67. NanoVation Therapeutics LNP-mRNA Therapy Product and Services
Table 68. NanoVation Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. NanoVation Therapeutics Recent Developments/Updates
Table 70. NanoVation Therapeutics Competitive Strengths & Weaknesses
Table 71. CureVac Basic Information, Manufacturing Base and Competitors
Table 72. CureVac Major Business
Table 73. CureVac LNP-mRNA Therapy Product and Services
Table 74. CureVac LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. CureVac Recent Developments/Updates
Table 76. CureVac Competitive Strengths & Weaknesses
Table 77. Sanofi Basic Information, Manufacturing Base and Competitors
Table 78. Sanofi Major Business
Table 79. Sanofi LNP-mRNA Therapy Product and Services
Table 80. Sanofi LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sanofi Recent Developments/Updates
Table 82. Sanofi Competitive Strengths & Weaknesses
Table 83. Promab Basic Information, Manufacturing Base and Competitors
Table 84. Promab Major Business
Table 85. Promab LNP-mRNA Therapy Product and Services
Table 86. Promab LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Promab Recent Developments/Updates
Table 88. Promab Competitive Strengths & Weaknesses
Table 89. Grand Pharm Basic Information, Manufacturing Base and Competitors
Table 90. Grand Pharm Major Business
Table 91. Grand Pharm LNP-mRNA Therapy Product and Services
Table 92. Grand Pharm LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Grand Pharm Recent Developments/Updates
Table 94. Grand Pharm Competitive Strengths & Weaknesses
Table 95. Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 96. Arcturus Therapeutics Major Business
Table 97. Arcturus Therapeutics LNP-mRNA Therapy Product and Services
Table 98. Arcturus Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Arcturus Therapeutics Recent Developments/Updates
Table 100. Arcturus Therapeutics Competitive Strengths & Weaknesses
Table 101. Synplogen Basic Information, Manufacturing Base and Competitors
Table 102. Synplogen Major Business
Table 103. Synplogen LNP-mRNA Therapy Product and Services
Table 104. Synplogen LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Synplogen Recent Developments/Updates
Table 106. Synplogen Competitive Strengths & Weaknesses
Table 107. CSPC Basic Information, Manufacturing Base and Competitors
Table 108. CSPC Major Business
Table 109. CSPC LNP-mRNA Therapy Product and Services
Table 110. CSPC LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. CSPC Recent Developments/Updates
Table 112. CSPC Competitive Strengths & Weaknesses
Table 113. Beijing JenKem Technology Basic Information, Manufacturing Base and Competitors
Table 114. Beijing JenKem Technology Major Business
Table 115. Beijing JenKem Technology LNP-mRNA Therapy Product and Services
Table 116. Beijing JenKem Technology LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Beijing JenKem Technology Recent Developments/Updates
Table 118. Beijing JenKem Technology Competitive Strengths & Weaknesses
Table 119. Starna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 120. Starna Therapeutics Major Business
Table 121. Starna Therapeutics LNP-mRNA Therapy Product and Services
Table 122. Starna Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Starna Therapeutics Recent Developments/Updates
Table 124. Starna Therapeutics Competitive Strengths & Weaknesses
Table 125. Global Key Players of LNP-mRNA Therapy Upstream (Raw Materials)
Table 126. Global LNP-mRNA Therapy Typical Customers
Table 1. World LNP-mRNA Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World LNP-mRNA Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World LNP-mRNA Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World LNP-mRNA Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World LNP-mRNA Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World LNP-mRNA Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World LNP-mRNA Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World LNP-mRNA Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World LNP-mRNA Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key LNP-mRNA Therapy Players in 2025
Table 12. World LNP-mRNA Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global LNP-mRNA Therapy Company Evaluation Quadrant
Table 14. Head Office of Key LNP-mRNA Therapy Players
Table 15. LNP-mRNA Therapy Market: Company Product Type Footprint
Table 16. LNP-mRNA Therapy Market: Company Product Application Footprint
Table 17. LNP-mRNA Therapy Mergers & Acquisitions Activity
Table 18. United States VS China LNP-mRNA Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China LNP-mRNA Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based LNP-mRNA Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies LNP-mRNA Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies LNP-mRNA Therapy Revenue Market Share (2021-2026)
Table 23. China Based LNP-mRNA Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies LNP-mRNA Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies LNP-mRNA Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based LNP-mRNA Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies LNP-mRNA Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies LNP-mRNA Therapy Revenue Market Share (2021-2026)
Table 29. World LNP-mRNA Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World LNP-mRNA Therapy Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World LNP-mRNA Therapy Market Size by Type (2027-2032) & (USD Million)
Table 32. World LNP-mRNA Therapy Market Size by Treatment Direction, (USD Million), 2021 & 2025 & 2032
Table 33. World LNP-mRNA Therapy Market Size Value by Treatment Direction (2021-2026) & (USD Million)
Table 34. World LNP-mRNA Therapy Market Size by Treatment Direction (2027-2032) & (USD Million)
Table 35. World LNP-mRNA Therapy Market Size by Mechanisms of Action, (USD Million), 2021 & 2025 & 2032
Table 36. World LNP-mRNA Therapy Market Size Value by Mechanisms of Action (2021-2026) & (USD Million)
Table 37. World LNP-mRNA Therapy Market Size by Mechanisms of Action (2027-2032) & (USD Million)
Table 38. World LNP-mRNA Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World LNP-mRNA Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World LNP-mRNA Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Genevant Sciences Basic Information, Manufacturing Base and Competitors
Table 42. Genevant Sciences Major Business
Table 43. Genevant Sciences LNP-mRNA Therapy Product and Services
Table 44. Genevant Sciences LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Genevant Sciences Recent Developments/Updates
Table 46. Genevant Sciences Competitive Strengths & Weaknesses
Table 47. Moderna Basic Information, Manufacturing Base and Competitors
Table 48. Moderna Major Business
Table 49. Moderna LNP-mRNA Therapy Product and Services
Table 50. Moderna LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Moderna Recent Developments/Updates
Table 52. Moderna Competitive Strengths & Weaknesses
Table 53. BioNTech Basic Information, Manufacturing Base and Competitors
Table 54. BioNTech Major Business
Table 55. BioNTech LNP-mRNA Therapy Product and Services
Table 56. BioNTech LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. BioNTech Recent Developments/Updates
Table 58. BioNTech Competitive Strengths & Weaknesses
Table 59. Pfizer Basic Information, Manufacturing Base and Competitors
Table 60. Pfizer Major Business
Table 61. Pfizer LNP-mRNA Therapy Product and Services
Table 62. Pfizer LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Pfizer Recent Developments/Updates
Table 64. Pfizer Competitive Strengths & Weaknesses
Table 65. NanoVation Therapeutics Basic Information, Manufacturing Base and Competitors
Table 66. NanoVation Therapeutics Major Business
Table 67. NanoVation Therapeutics LNP-mRNA Therapy Product and Services
Table 68. NanoVation Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. NanoVation Therapeutics Recent Developments/Updates
Table 70. NanoVation Therapeutics Competitive Strengths & Weaknesses
Table 71. CureVac Basic Information, Manufacturing Base and Competitors
Table 72. CureVac Major Business
Table 73. CureVac LNP-mRNA Therapy Product and Services
Table 74. CureVac LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. CureVac Recent Developments/Updates
Table 76. CureVac Competitive Strengths & Weaknesses
Table 77. Sanofi Basic Information, Manufacturing Base and Competitors
Table 78. Sanofi Major Business
Table 79. Sanofi LNP-mRNA Therapy Product and Services
Table 80. Sanofi LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sanofi Recent Developments/Updates
Table 82. Sanofi Competitive Strengths & Weaknesses
Table 83. Promab Basic Information, Manufacturing Base and Competitors
Table 84. Promab Major Business
Table 85. Promab LNP-mRNA Therapy Product and Services
Table 86. Promab LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Promab Recent Developments/Updates
Table 88. Promab Competitive Strengths & Weaknesses
Table 89. Grand Pharm Basic Information, Manufacturing Base and Competitors
Table 90. Grand Pharm Major Business
Table 91. Grand Pharm LNP-mRNA Therapy Product and Services
Table 92. Grand Pharm LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Grand Pharm Recent Developments/Updates
Table 94. Grand Pharm Competitive Strengths & Weaknesses
Table 95. Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 96. Arcturus Therapeutics Major Business
Table 97. Arcturus Therapeutics LNP-mRNA Therapy Product and Services
Table 98. Arcturus Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Arcturus Therapeutics Recent Developments/Updates
Table 100. Arcturus Therapeutics Competitive Strengths & Weaknesses
Table 101. Synplogen Basic Information, Manufacturing Base and Competitors
Table 102. Synplogen Major Business
Table 103. Synplogen LNP-mRNA Therapy Product and Services
Table 104. Synplogen LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Synplogen Recent Developments/Updates
Table 106. Synplogen Competitive Strengths & Weaknesses
Table 107. CSPC Basic Information, Manufacturing Base and Competitors
Table 108. CSPC Major Business
Table 109. CSPC LNP-mRNA Therapy Product and Services
Table 110. CSPC LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. CSPC Recent Developments/Updates
Table 112. CSPC Competitive Strengths & Weaknesses
Table 113. Beijing JenKem Technology Basic Information, Manufacturing Base and Competitors
Table 114. Beijing JenKem Technology Major Business
Table 115. Beijing JenKem Technology LNP-mRNA Therapy Product and Services
Table 116. Beijing JenKem Technology LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Beijing JenKem Technology Recent Developments/Updates
Table 118. Beijing JenKem Technology Competitive Strengths & Weaknesses
Table 119. Starna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 120. Starna Therapeutics Major Business
Table 121. Starna Therapeutics LNP-mRNA Therapy Product and Services
Table 122. Starna Therapeutics LNP-mRNA Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Starna Therapeutics Recent Developments/Updates
Table 124. Starna Therapeutics Competitive Strengths & Weaknesses
Table 125. Global Key Players of LNP-mRNA Therapy Upstream (Raw Materials)
Table 126. Global LNP-mRNA Therapy Typical Customers
LIST OF FIGURES
Figure 1. LNP-mRNA Therapy Picture
Figure 2. World LNP-mRNA Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World LNP-mRNA Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World LNP-mRNA Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World LNP-mRNA Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 13. LNP-mRNA Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World LNP-mRNA Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of LNP-mRNA Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for LNP-mRNA Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for LNP-mRNA Therapy Markets in 2025
Figure 27. United States VS China: LNP-mRNA Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: LNP-mRNA Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World LNP-mRNA Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World LNP-mRNA Therapy Market Size Market Share by Type in 2025
Figure 31. Passive Targeting
Figure 32. Active Targeting
Figure 33. World LNP-mRNA Therapy Market Size Market Share by Type (2021-2032)
Figure 34. World LNP-mRNA Therapy Market Size by Treatment Direction, (USD Million), 2021 & 2025 & 2032
Figure 35. World LNP-mRNA Therapy Market Size Market Share by Treatment Direction in 2025
Figure 36. Vaccines
Figure 37. Cancer Immunotherapy
Figure 38. Genetic Disease Therapy
Figure 39. Others
Figure 40. World LNP-mRNA Therapy Market Size Market Share by Treatment Direction (2021-2032)
Figure 41. World LNP-mRNA Therapy Market Size by Mechanisms of Action, (USD Million), 2021 & 2025 & 2032
Figure 42. World LNP-mRNA Therapy Market Size Market Share by Mechanisms of Action in 2025
Figure 43. Protein Replacement Therapy
Figure 44. Immune Activation Therapy
Figure 45. Gene Regulation Therapy
Figure 46. World LNP-mRNA Therapy Market Size Market Share by Mechanisms of Action (2021-2032)
Figure 47. World LNP-mRNA Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World LNP-mRNA Therapy Market Size Market Share by Application in 2025
Figure 49. Hospital
Figure 50. Clinic
Figure 51. Others
Figure 52. World LNP-mRNA Therapy Market Size Market Share by Application (2021-2032)
Figure 53. LNP-mRNA Therapy Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. LNP-mRNA Therapy Picture
Figure 2. World LNP-mRNA Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World LNP-mRNA Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World LNP-mRNA Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World LNP-mRNA Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company LNP-mRNA Therapy Revenue (2021-2032) & (USD Million)
Figure 13. LNP-mRNA Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World LNP-mRNA Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India LNP-mRNA Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of LNP-mRNA Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for LNP-mRNA Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for LNP-mRNA Therapy Markets in 2025
Figure 27. United States VS China: LNP-mRNA Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: LNP-mRNA Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World LNP-mRNA Therapy Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World LNP-mRNA Therapy Market Size Market Share by Type in 2025
Figure 31. Passive Targeting
Figure 32. Active Targeting
Figure 33. World LNP-mRNA Therapy Market Size Market Share by Type (2021-2032)
Figure 34. World LNP-mRNA Therapy Market Size by Treatment Direction, (USD Million), 2021 & 2025 & 2032
Figure 35. World LNP-mRNA Therapy Market Size Market Share by Treatment Direction in 2025
Figure 36. Vaccines
Figure 37. Cancer Immunotherapy
Figure 38. Genetic Disease Therapy
Figure 39. Others
Figure 40. World LNP-mRNA Therapy Market Size Market Share by Treatment Direction (2021-2032)
Figure 41. World LNP-mRNA Therapy Market Size by Mechanisms of Action, (USD Million), 2021 & 2025 & 2032
Figure 42. World LNP-mRNA Therapy Market Size Market Share by Mechanisms of Action in 2025
Figure 43. Protein Replacement Therapy
Figure 44. Immune Activation Therapy
Figure 45. Gene Regulation Therapy
Figure 46. World LNP-mRNA Therapy Market Size Market Share by Mechanisms of Action (2021-2032)
Figure 47. World LNP-mRNA Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World LNP-mRNA Therapy Market Size Market Share by Application in 2025
Figure 49. Hospital
Figure 50. Clinic
Figure 51. Others
Figure 52. World LNP-mRNA Therapy Market Size Market Share by Application (2021-2032)
Figure 53. LNP-mRNA Therapy Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
